No Detail Found!

Berberine attenuates isoniazid-induced hepatotoxicity by modulating peroxisome proliferator-activated receptor ‘Y, oxidative stress and inflammation.

Author(s)
Ayman M. Mahmoud Physiology Division, Department of Zoology, Faculty of Science, Beni-Suef University, Egypt
Mousa O. Germoush Department of Biology, Faculty of Science, Aljouf University, Sakaka, Saudi Arabia
Ayman S. Soliman Department of Physiology, Faculty of Medicine, Beni-Suef University, Egypt
Abstract
The antituberculosis drug-in duced hepatotoxicity is a leading cause of liver injury in many countries. The current study aimed to investigate the possible protective effects of the isoquinoline alkaloid berberine against isoniazid (INH)-induced hepatotoxicity in rats. The experimental rats received 100 mg kg-1 b.wt. INH and concurrently administered berberine at doses of 25 and 50 mg kg-1 orally for 45 days. To evaluate the hepatoprotective effects of berberine, e, serum markers of the liver function, serum pro-in flammatory cytokines es and liver oxidant/antioxidant biomarkers were assayed. In addition, gene expression levels of inducible nitric oxide synthase (NOS), nuclear factor-kappa B (NF-KB) and peroxisome proliferator-activated receptor gamma (PPARy) were determined. INH induced hepatic damage evidenced by the significantly elevated serum transamin ases, serum pro-in flammatory cytokines and liver lipid peroxidation and nitric oxide levels. Consequently, serum albumin, liver glutathione and activities of the antioxidant enzymes were significantly declined. Further, INH administration produced a significant upregulation of liver iNOS and NF-KB and downregulation PPARy mRNA expressions. Concurrent supplementation of berberine restored the altered markers to an almost normal state, in a dose-dependent manner. In conclusion , Berberine protects again` st INH-induced oxidative stress and inflammation leading to liver injury. The protective effects of berberine can be attributed to its ability to upregulate PPARy and subsequently suppress NF-KB, iNOS and release of the pro-inflammatory cytokines.
Publication Details
Page(s) 451-460
DOI DOI not available
Published Journal: International Journal of Pharmacology, Volume: 10, Issue: 8, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

44

Views